Rowe D J, Gedeon G
Br J Exp Pathol. 1983 Jun;64(3):306-11.
Rats were treated with Indomethacin (Indo; 2 mg/kg/d) with or without concomitant infusion of prostaglandin (PG)E2 (100 micrograms/d) to investigate the effects of inhibition of PG synthesis and PG replacement on the urinary excretion of total nitrogenous compounds, urea and creatinine and on the plasma concentration of urea and creatinine. The results indicated: (1) Indo significantly reduced the urine excretion of nitrogen, urea and creatinine within 48 hours of drug administration. (2) This effect was reversible on stopping the drug. (3) PGE2 infusion completely reversed the effect on urine creatinine and partly reversed the effects on urinary nitrogen and urea excretion. (4) Plasma urea concentrations were reduced by Indo and remained low during PGE2 infusion whereas plasma creatinine progressively increased during the study. The results support the hypotheses: (1) that Indo reduces the renal excretion of end products of nitrogen metabolism by inhibition of endogenous PG production and (2) that production of urea and therefore protein and amino acid metabolism is altered by Indo treatment in addition to its renal action.
用吲哚美辛(Indo;2毫克/千克/天)对大鼠进行治疗,同时或不伴有前列腺素(PG)E2(100微克/天)的输注,以研究抑制PG合成和PG替代对总含氮化合物、尿素和肌酐的尿排泄以及尿素和肌酐血浆浓度的影响。结果表明:(1)吲哚美辛在给药后48小时内显著降低了氮、尿素和肌酐的尿排泄。(2)停药后这种效应是可逆的。(3)输注PGE2完全逆转了对尿肌酐的影响,部分逆转了对尿氮和尿素排泄的影响。(4)吲哚美辛降低了血浆尿素浓度,在输注PGE2期间仍保持较低水平,而在研究期间血浆肌酐逐渐升高。这些结果支持以下假设:(1)吲哚美辛通过抑制内源性PG产生来减少氮代谢终产物的肾排泄;(2)除了其肾脏作用外,吲哚美辛治疗还改变了尿素的产生,因此也改变了蛋白质和氨基酸代谢。